New Zealand markets open in 7 hours 21 minutes

Ocular Therapeutix, Inc. (OCUL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.66+0.16 (+2.91%)
At close: 04:00PM EST
5.75 +0.09 (+1.59%)
After hours: 07:36PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
38,563
17,403
4,227
1,990
Cost of revenue
3,978
2,083
2,325
465
Gross profit
34,585
15,320
1,902
1,525
Operating expenses
Research development
45,129
28,694
41,091
36,915
Selling general and administrative
63,787
49,473
46,613
23,728
Total operating expenses
108,916
78,167
87,704
60,643
Operating income or loss
-74,331
-62,847
-85,802
-59,118
Interest expense
6,717
6,768
6,101
1,739
Total other income/expenses net
-7,300
-86,189
4,302
-
Income before tax
-88,315
-155,636
-86,372
-59,978
Income from continuing operations
-88,315
-155,636
-86,372
-59,978
Net income
-88,315
-155,636
-86,372
-59,978
Net income available to common shareholders
-88,315
-155,636
-86,372
-59,978
Basic EPS
-
-2.56
-1.91
-1.57
Diluted EPS
-
-2.56
-1.91
-1.57
Basic average shares
-
60,752
45,273
38,115
Diluted average shares
-
60,752
45,273
38,115
EBITDA
-
-146,095
-77,741
-55,953